Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
7.520
-0.130 (-1.70%)
Streaming Delayed Price
Updated: 9:44 AM EDT, Jun 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Arcturus (ARCT) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
Arcturus (ARCT) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Arcturus Therapeutics Holdings (NASDAQ:ARCT) Q1 2026 Results: Revenue Miss Weighs on Sentiment as Pipeline Advances
↗
May 07, 2026
Via
Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
May 07, 2026
Via
Chartmill
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
March 25, 2026
The widely followed investor has been buying stocks trading well below their all-time highs.
Via
The Motley Fool
Arcturus Therapeutics (NASDAQ:ARCT) Stock Falls After Q4 2025 Revenue Miss
↗
March 03, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Preview: Arcturus Therapeutics's Earnings
↗
November 07, 2025
Via
Benzinga
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
↗
March 23, 2026
The growing investing icon was skimpy on her purchases last week, making the names she did buy that much more interesting.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Arcturus (ARCT) Q4 2025 Earnings Call Transcript
↗
March 03, 2026
Arcturus (ARCT) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Lawsuit
Arcturus Therapeutics (NASDAQ:ARCT) Reports Mixed Q3 2025 Results, Extends Cash Runway to 2028
↗
November 10, 2025
Arcturus Q3 2025 results show a revenue miss but a smaller-than-expected loss. The company advances its CF and OTC programs, with cash extending into 2028.
Via
Chartmill
This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
↗
October 24, 2025
Via
Benzinga
Cathie Wood Goes Shopping: 3 Stocks She Just Bought
↗
October 23, 2025
The growth-focused money manager only bought three stocks on Wednesday. Let's check out that shopping list.
Via
The Motley Fool
Topics
ETFs
Where Arcturus Therapeutics Stands With Analysts
↗
October 22, 2025
Via
Benzinga
Arcturus' Investigational Inhaled Therapy Lacks Meaningful Lung Function Improvement, Analyst Notes Mixed Picture
↗
October 22, 2025
Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but no initial FEV₁ improvement.
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
October 22, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results
↗
October 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 22, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
October 22, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
October 22, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings
↗
October 22, 2025
Via
Benzinga
Topics
Stocks
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
↗
October 22, 2025
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing.
Via
Stocktwits
Arcturus Crashes 55% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
↗
October 22, 2025
The company is working on a treatment for cystic fibrosis using messenger RNA, or mRNA, technology.
Via
Investor's Business Daily
Wednesday's pre-market session: top gainers and losers
↗
October 22, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 22, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 29, 2025
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
↗
September 18, 2025
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
Via
Benzinga
Topics
Artificial Intelligence
Forecasting The Future: 5 Analyst Projections For Arcturus Therapeutics
↗
September 04, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
August 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 13, 2025
Via
Benzinga
Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday
↗
August 13, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
